Los Angeles, 28 August 2006 – Elsevier (www.elsevier.com), a leading scientific, technical and medical publisher and faculty from the University of California, Los Angeles School of Dentistry, Section of Periodontics announce the publication of the 10th edition of Carranza's Clinical Periodontology.
The landmark 10th edition is authored by Michael G. Newman, DDS, Henry H. Takei, DDS, MS, Perry R. Klokkevold, DDS, MS and Editor Emeritus, Fermin A. Carranza, DR ODONT. These authors have recruited the top experts from around the world to contribute to this edition. This 10th Edition is considered to be the most comprehensive and complete resource in Periodontology.
Carranza's Clinical Periodontology (www.clinicalperiodontology.com) is the most widely used periodontics text in the world and provides the most up-to-date information on new technology and emerging concepts. A new section devoted to Evidence-Based Decision Making provides an in-depth presentation on critical thinking skills, accessing evidence and implementing evidence-based decisions in clinical practice.
For the first time in the field of Periodontology, this leading reference is also available as a global web-based tool for students, clinicians and researchers. The E-ditionTM provides the following:
"The E-dition of Carranza's Clinical Periodontology gives our students, residents and faculty a tremendous opportunity to have point-of-care technology in our classroom and clinics. We have always required the print product and the digital product gives us a very powerful tool." Dr. Bashar Bakdash, Professor and Director, Division of Periodontology, School of Dentistry, University of Minnesota.
"The Section of Periodontics here at UCLA is proud to be associated with this publication. It underscores our commitment to our students, residents and to the cutting edge research done here." Dr. E. B. Kenney, Chairman, Section of Periodontics, UCLA School of Dentistry.
"We are extremely pleased to publish the landmark 10th edition of the text. Dr. Newman and his authors have put together a world-class team and the E-dition is the first of its kind in this field." John J. Dolan, Senior Editor, Elsevier Inc., St. Louis, MO.
About Elsevier Elsevier is a world-leading publisher of scientific, technical and medical information products and services. Working in partnership with the global science and health communities, Elsevier's 7,000 employees in over 70 offices worldwide publish more than 2,000 journals and 1,900 new books per year, in addition to offering a suite of innovative electronic products, such as ScienceDirect (http://www.sciencedirect.com/), MD Consult (http://www.mdconsult.com/), Scopus (http://www.info.scopus.com/), bibliographic databases, and online reference works.
Elsevier (http://www.elsevier.com/) is a global business headquartered in Amsterdam, The Netherlands and has offices worldwide. Elsevier is part of Reed Elsevier Group plc (http://www.reedelsevier.com/), a world-leading publisher and information provider. Operating in the science and medical, legal, education and business-to-business sectors, Reed Elsevier provides high-quality and flexible information solutions to users, with increasing emphasis on the Internet as a means of delivery. Reed Elsevier's ticker symbols are REN (Euronext Amsterdam), REL (London Stock Exchange), RUK and ENL (New York Stock Exchange).
Last reviewed: By John M. Grohol, Psy.D. on 21 Feb 2009
Published on PsychCentral.com. All rights reserved.